Anna Jansen

In utero and early life exposures to smoking are associated with systemic autoimmune rheumatic diseases

Takuma Ohnishi, Min Shi, Rita Volochayev, Sharon H. Jackson et autres

OBJECTIVE: Systemic autoimmune rheumatic diseases (SARDs) are influenced by genetic and environmental factors. We examined pregnancy complications, early life events (birth season, birth order, feeding), and exposures to tobacco smoking in relation to SARD diagnosis. METHODS: In a case-control study, probands with …

us (code pays fourni par la source)

Erratum corrige: Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults

Iazsmin Bauer Ventura, Adam I. Schiffenbauer, Min Shi, Rita Volochayev et autres

Erratum Corrige; Authors: I. Bauer Ventura, M.E. Goldberg, A. Schiffenbauer, M. Shi, R. Volochayev, S.H. Jackson, A. Jansen, N. Bayat, P. Noroozi Farhadi, C.G. Parks, C.R. Weinberg, A. Picardi, F.W. Miller, L.G. Rider

us, it (code pays fourni par la source)

Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults

Iazsmin Bauer Ventura, Adam I. Schiffenbauer, Min Shi, Rita Volochayev et autres

OBJECTIVES: To assess the association between life events and subsequent diagnosis of systemic autoimmune rheumatic diseases (SARDs) by comparing siblings discordant for SARDs and unrelated controls. METHODS: Life events 12 months prior to SARD diagnosis/reference date were queried using the Interview for …

us, it (code pays fourni par la source)

Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features

Matthew A. Sherman, Rose Graf, Sara E. Sabbagh, Angeles S. Galindo‐Feria et autres

OBJECTIVES: Four-and-a-half LIM domains 1 (FHL1) is a muscle-specific protein. Autoantibodies against FHL1 were recently discovered in adults with idiopathic inflammatory myopathies (IIMs) and were found to be associated with clinical features and outcomes indicative of increased disease severity. Anti-FHL1 autoantibodies have …

us, se (code pays fourni par la source)

Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes

Jonathan C. Scalabrini, Adam I. Schiffenbauer, Payam Noroozi Farhadi, Rita Volochayev et autres

BACKGROUND: Environmental exposures have been associated with the juvenile idiopathic inflammatory myopathies (JIIM). We undertook a questionnaire-based study to evaluate patient-reported exposures as possible risk factors for JIIM. FINDINGS: One-hundred-seven patients with JIIM were enrolled in a myositis natural history protocol and …

us (code pays fourni par la source)

Additional file 1: TableS1. of TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

John Kingswood, Guillaume d’Augères, Elena Belousova, José Ferreira et autres

Age and Gender Distribution of TSC manifestations reported in TOSCA. (DOCX 13 kb)

Additional file 1: TableS1. of TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

John Kingswood, Guillaume d’Augères, Elena Belousova, José Ferreira et autres

Age and Gender Distribution of TSC manifestations reported in TOSCA. (DOCX 13 kb)

Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies

Lawrence Yao, Adrienne L. Yip, Joseph A. Shrader, Sepehr Mesdaghinia et autres

OBJECTIVE: This study examines the utility of MRI, including T2 maps and T2 maps corrected for muscle fat content, in evaluating patients with idiopathic inflammatory myopathy. METHODS: A total of 44 patients with idiopathic inflammatory myopathy, 18 of whom were evaluated after …

us (code pays fourni par la source)

Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Lisa G. Rider, Adrienne L. Yip, Iren Horkayne‐Szakaly, Rita Volochayev et autres

OBJECTIVES: We aimed to assess changes in myositis core set measures and ancillary clinical and laboratory data from the National Institutes of Health's subset of patients enrolled in the Rituximab in Myositis trial. METHODS: Eighteen patients (5 dermatomyositis, 8 polymyositis, 5 juvenile …

us (code pays fourni par la source)